Picture of Merck & Co logo

MRK Merck & Co Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Merck & Co, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4,52312,35814,52637717,133
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items7,4112,1895,01012,8614,752
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-4,601-3,839-2,782-2,205-3,667
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities10,25314,10919,09513,00621,468
Capital Expenditures-4,429-4,448-4,388-3,863-3,372
Purchase of Fixed Assets
Other Investing Cash Flow Items-5,014-12,107-572-10,220-4,362
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-9,443-16,555-4,960-14,083-7,734
Financing Cash Flow Items-4368,210-240-328-372
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,8322,593-9,119-4,810-7,032
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,769144,606-5,8646,409